Why Life360, Nufarm, Pilbara Minerals, and Seek shares are racing higher

These ASX shares are having a strong session on Wednesday. But why?

| More on:
A young woman wearing overalls and a yellow t-shirt kicks one leg in the air showing excitement over the latest ASX 200 shares to hit 52-week highs

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It has been an excellent session for the S&P/ASX 200 Index (ASX: XJO). In afternoon trade, the benchmark index is up 1.3% to 7,095.9 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

Life360 Inc (ASX: 360)

The Life360 share price is up 7% to $9.00. This follows the release of the location technology company's quarterly update. Life360 reported a 41% increase in annualised monthly revenue to US$259.1 million and its second consecutive quarter of positive operating cash flow. This was underpinned by a 24% lift in monthly active users to 58.4 million and a 17% lift in paying circles to 1.75 million.

Nufarm Ltd (ASX: NUF)

The Nufarm share price is up 9% to $4.85. Investors have been buying the agricultural chemicals company's shares following the release of its half-year results. Nufarm reported a 3% increase in statutory net profit after tax to $111 million.

Pilbara Minerals Ltd (ASX: PLS)

The Pilbara Minerals share price is up 5% to $3.68. Investors have been piling into the lithium industry on Wednesday following a very strong night of trade for battery materials stocks on Wall Street. A lower-than-expected inflation reading has given sentiment on this side of the market a major boost.

Seek Ltd (ASX: SEK)

The Seek share price is up 6% to $23.33. This follows the release of the job listings giant's annual general meeting update. At the event, management reaffirmed its guidance for FY 2024. It continues to expect revenue in the range of $1.18 billion to $1.26 billion and EBITDA in the range of $520 million to $560 million.

Motley Fool contributor James Mickleboro has positions in Life360 and Seek. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Life360. The Motley Fool Australia has recommended Seek. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup
Share Gainers

Here are the top 10 ASX 200 shares today

It was a dour Tuesday for ASX investors.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Brightstar Resources, Immutep, Pilbara Minerals, and Race Oncology shares are roaring higher

These shares are having a strong session on Tuesday. But why?

Read more »

A graphic of a pink rocket taking off above an increasing chart.
Healthcare Shares

Guess which ASX 300 healthcare share is rocketing 28% on global expansion news

Investors are piling into the ASX 300 healthcare share on Tuesday. Let’s see why.

Read more »

A neon sign says 'Top Ten'.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a Garfield kind of Monday for investors.

Read more »

Happy shareholders clap and smile as they listen to a company earnings report.
Share Gainers

Why Artrya, Clinuvel, Imugene, and Pilbara Minerals shares are storming higher today

These shares are starting the week in a positive fashion. But why?

Read more »

An old-fashioned panel of judges each holding a card with the number 10
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

Excited couple celebrating success while looking at smartphone.
Healthcare Shares

Up 680% since July, here's why 2025 was a breakout year for this hot ASX stock

With consistent contract wins, FDA clearance, and backing from Pro Medicus, 4D Medical is showing that there is a commercial…

Read more »

A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
Share Gainers

4 ASX 200 stocks smashing the benchmark this week

Investors have been piling into these four ASX 200 stocks this week. Let’s see why.

Read more »